This year's Albert Lasker Award for Basic Medical Research is to be conferred on Ralph M. Steinman, Henry G. Kunkel Professor and Senior Physician at New York's Rockefeller University, for his discovery of dendritic cells (DCs) and for demonstrating that they are the principal antigen-presenting cells of the immune system. Steinman showed that the state of activation and differentiation of DCs determines both the magnitude and the nature of the adaptive immune responses mounted by an individual, thus revealing that the DC is the central interpreter of the nature of the threat posed by a foreign entity and the key determinant of the type of immune response that should be mounted.
Steinman showed that a previously unrecognized population of stellate cells (Figure 1 ) found in virtually every organ of the body continuously samples the local environment, processing antigens and presenting them to other immune cells. He further discovered that the state of activation and differentiation of these cells determines both the magnitude and the nature of the adaptive immune responses mounted by an individual. Dendritic cells both maintain peripheral tolerance to self-antigens and initiate immunity to foreign substances. Indeed, it may be said that DCs are the sentinel cells that ensure that an immune response is appropriate in specificity, intensity, and type to the nature of the threat posed by the antigen-bearing entity.
The immune response may be thought of as guided by three principles or laws. The first is that immune responses of immense diversity can be generated (Universality). The second is that powerful mechanisms exist to prevent or limit responses to self (Tolerance), and the third is that responses are mounted only to entities that constitute a threat and the response mounted is appropriate to the type of threat (Appropriateness). This third critical element of immunity had largely been ignored prior to Steinman's work because immunologists concerned themselves with the two other major themes, that is, how specificity is generated and how autoimmune responses are avoided or controlled. The principle of "appropriateness" of a response could be grappled with only when the cell responsible for the initiation of that response could be studied.
Establishing how the immune system is organized to enforce each of these laws represented great scientific accomplishments. The central enigma of how to create diversity was solved brilliantly when molecular biology could be applied to lymphocytes. It was demonstrated that recombination allowed single members of distinct families of genetic elements to be assembled into genes that encoded the variable regions of the H and L chains of antibodies. Furthermore, at the positions where these elements joined, a "random sequence generator" created a virtually unlimited set of sequences that are found in antibody molecules at the sites shown by structural analysis to contact antigen. This strategy allowed a relatively limited amount of genetic information to create a virtually unlimited number of distinct antigencombining sequences. Indeed, the potential number of distinct antibodies (and T cell receptors) far exceeds the actual number of lymphocytes in the body. Although the principle of diversity generation for T cells is essentially the same as for antibodies, the T cellrecognition mechanism has a critical "twist" that brings into play an entirely new principle of recognition in the immune system and, indeed, underlies much of the importance of the Steinman discovery.
Antibodies recognize structures found on the surface of microbial pathogens and other antigenic substances, consistent with their major function of eliminating pathogens prior to their entry into a cell. By contrast, T cells recognize structures derived from entities that are within cells, either endogenously synthesized or imported into the cell by infection or by various uptake mechanisms. How T cells "see" intracellular molecules was the great enigma that made understanding T cell antigen recognition the "holy grail" of immunology from the 1960s to the 1980s. Indeed, there are actually two distinct recognition events in the T cell activation process. The first, and unanticipated, one was that the cell in which the antigen resided was able to generate peptides derived from the antigen and to load them into a specialized set of proteins, the major histocompatibility complex (MHC) molecules. MHC molecules with their loaded peptides were then shuttled to the cell surface, where they were available for recognition by T cell receptors of the appropriate specificity. The peptideloading event depended upon the capacity of a binding site within the MHC molecule to recognize key elements in the peptide sequence and to bind that peptide depending on this recognition. Thus, both the MHC molecule and the T cell receptor may be thought of as antigen-recognition molecules that are key to T cell activation. Simple expression of peptide/ MHC complexes on the cell surface is, however, insufficient for activation of a T cell, even one that expresses a receptor that could interact with that complex with high affinity. For the initiation of a T cell response, presentation of antigen needs to be mediated by a specialized cell endowed with a set of properties that allows an appropriate response to ensue.
Of course, that specialized cell is Steinman's dendritic cell (DC). Steinman first described the DC in a series of papers, published between 1973 and 1975, when he was a postdoctoral fellow in the laboratory of the late Zanvil Cohn at the Rockefeller University Cohn, 1973, 1974; Steinman et al., , 1975 . Steinman and Cohn and their colleagues showed that DCs are widely distributed in lymphoid organs (later, it was recognized that these cells are found in virtually every organ). Steinman worked out techniques to obtain this rare cell type with high purity and to maintain these cells in culture. He showed that DCs are the major (if not sole) stimulants of the mixed lymphocyte response (MLR), a laboratory surrogate of an immune response. DCs are at least 100 to 300 times more potent in initiating this response than are other cells, mainly B cells and macrophages, that also express the principle stimulants of MLRs, the class II MHC molecules (Steinman et al., 1983) . Furthermore, DCs were shown to be extremely efficient stimulants of more conventional antigenspecific responses by CD4 T cells and to be potent inducers of antigenspecific cytotoxic T cell responses (Nussenzweig et al., 1980) .
With his colleagues, Steinman demonstrated that DCs exist in the human as well as the mouse and that they could be found in human blood (Van Voorhis et al., 1982) . He and his colleagues developed important tools to study DCs, including key monoclonal antibodies that not only made DC identification more straightforward but also proved to be specific for molecules with important functional and targeting roles. An important insight into DC physiology was the recognition that an epidermal cell, the Langerhans cell, would develop into a DC in tissue culture but that the two cell types differed in several critical features (Schuler and Steinman, 1985) . The Langerhans cell expresses Fc receptors, allowing it to efficiently capture exogenous antigens in immune complexes, but it lacks surface expression of class II MHC molecules, making it ineffective as an antigen-presenting cell. By contrast, the DC derived from the Langerhans cell lacks Fc receptors and other antigen-capture molecules but expresses extremely high levels of MHC molecules allowing it to be a highly efficient antigen-presenting cell.
This insight led to the concept that Langerhan's cells and other types of tissue DCs act as sentinels throughout the body, efficiently capturing newly introduced antigens or antigens initially taken up by, or produced in, other cell types (Figure 1) . Indeed, cells of the DC family were subsequently shown to express a variety of cell-surface molecules in addition to Fc receptors that allow them to capture antigens. These include receptors for complement, mannose receptors and lectins, and also receptors for dying cells, to name but a few. Furthermore, DCs possess receptors (including Tolllike receptors) that enable them to detect the presence of potential pathogens, as well as receptors that serve as a link to other cells of the innate immune system. Under stimulatory conditions such as a local infection or inflammatory response, tissue DCs migrate to central lymphoid tissues, particularly the draining lymph nodes, carrying with them their ingested antigens. Such stimulated DCs also upregulate MHC molecules and enhance their antigen-processing capacity so that they now efficiently display peptide/ MHC complexes on their surface; many of these peptides are derived from the pathogen or from other antigens present in the tissue. Naive lymphocytes, including those specific for the peptide/MHC complexes expressed on the immigrating maturing DCs, are found in the T cell zone of the spleen and lymph nodes and, depending upon other properties of the DC, may receive potent stimulation to initiate the massive expansion and differentiation that characterize immune responses. A population of DCs resident in lymphoid tissues also exist. Although these express the MHC molecules needed for antigen presentation, they may be regarded as nonactivated and fail to express many of the self-surface molecules or to produce several of the cytokines expressed by tissue-activated DCs.
Let's now turn back to the role of the DC in imposing the Law of Appropriateness of the immune response. Indeed, interest in this phenomenon stems from a 1989 proposal by Charles A. Janeway that immune responses are regulated in amount and kind by interactions between pathogens and the innate immune system (Janeway, 1989) . Janeway proposed his now famous concept that pathogens express certain essential molecules that they could not easily alter; these serve as pathogen-associated molecular patterns (PAMPs). He postulated that cells of the innate immune system possess receptors for these entities, pattern recognition receptors (PRRs). The recognition of PAMPs by innate immune cells led to their instruction of the adaptive immune system as to whether and how it should respond to a microbial or other antigenic challenge. Jules Hoffman and his colleagues (Lemaitre et al., 1996) demonstrated that a molecule called Toll (previously identified in a genetic screen of dorsal-ventral pattern determination in Drosophila) unexpectedly also is required for antimicrobial resistance in flies, activating a signaling pathway analogous to the NF-κB pathway in mammalian cells. Then, in 1997, Janeway and his colleagues (Medzhitov et al., 1997) isolated a human homolog of Toll (a Toll-like receptor) and showed that it too could activate the NF-κB pathway, thereby inducing the expression of critical innate immune mediators. It became clear that the DC is the main "measurer" of the threat posed by a given introduced antigen-bearing entity, such as a microbial pathogen, because of its ability to recognize and respond to pathogens and to receive signals from other cell types that are responding to pathogens. Nonactivated DCs in tissues and resident DCs in lymphoid organs that had not been stimulated by ligands of Toll-like receptors failed to express a set of key "costimulatory molecules" and to produce important cytokines that are jointly essential for efficient induction of T cell responses. By contrast, appropriately activated DCs express the costimulants CD80 and CD86 and may produce the cytokines IL-12 and IL-23. Recently, activation of DCs was found to induce production of Notch ligands, which also may have a guiding role for the immune response.
Evidence exists that the type of DC and its differentiated state may direct responding T cells down different fate pathways. Thus, IL-12 and IL-23, which may be made by dendritic cells, will help in the first instance to promote Th1 differentiation by responding T cells and in the second to sustain differentiated Th17 cells. IL-10 produced by other DCs may favor induction of regulatory T cells. It has been argued that the expression of inducible costimulator (ICOS) ligand by DCs plays an important role in Th2 development as does the expression of particular Notch ligands.
Steinman and his colleagues showed that nonactivated DCs that express large numbers of MHC molecules could be efficient inducers of peripheral T cell tolerance. In an elegant study, Michel Nussenzweig, Steinman, and their associates provided evidence that when antigens are targeted to nonactivated DCs, the outcome of the interaction of that DC with the T cell bearing a cognate receptor is tolerance (Hawiger et al., 2001; Bonifaz et al., 2002) . These investigators proposed that immature DCs in secondary lymphoid tissues are continuously processing self-antigens, either endogenously produced within the DC or acquired by endocytosis from tissue fluid or from other cell types. These DCs then present the processed antigens to any T cells that may be specific for such self-antigens, rendering them tolerant. This immature DC-based tolerance may provide an important mechanism for maintaining a state of peripheral tolerance to self-antigens. Such continuous tolerance enforcement should serve to protect an individual against making a response to self-antigens when DCs are activated and are presenting both foreign and self-antigens. Those T cells specific for foreign antigens should be capable of responding, but those specific for self-antigens should have been eliminated or rendered tolerant through prior interactions, thus protecting the individual from developing autoimmunity in the course of responses to microbial pathogens.
What started as a single paper in the Journal of Experimental Medicine in 1973 is, according to the Institute of Scientific Information, only one of more than 35,000 papers published on DCs, with more than 20 of these having received over 1,000 citations. Indeed, it is no longer appropriate to think of DCs as a single cell type. It is clear that multiple types of DCs exist, with given tissues possessing several phenotypically and functionally distinct DC populations, each located in a precise position within the lymphoid organ.
Efforts are underway to take advantage of the unique properties of DCs for vaccine development. One could consider mechanisms to uniquely target antigens to activated DCs or alternatively to incorporate antigens into DCs in vitro with the goal of injecting antigen-loaded activated DCs into an organism to elicit a strong immune response. This strategy has been the focus of work aimed at developing therapeutic vaccines to shrink tumors. Given that many tumors are known to exert strong immunosuppressive effects, the singular potency of dendritic cell-based immunogens could have a striking effect.
The choice of Ralph Steinman to receive the 2007 Albert Lasker Award for Basic Medical Research honors a unique discovery of immense importance both for understanding the organization and regulation of the immune response and for manipulating the immune system to either enhance responses or, under the right circumstances, achieve tolerance. Steinman's achievement is particularly noteworthy in that he began as a lonely voice, championing an idea that was not at all popular, and through the sheer weight of the growing body of evidence that he and his colleagues amassed turned the study of DCs from a one-lab operation to one of the dominant themes of modern immunology.
